By contrast, Board members failed to include autism and obsessive-compulsive disorder among the list of qualifying conditions for which doctors may recommend medical marijuana.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“Few products had measured CBD concentrations within 10 percent of advertised concentrations, with most falling below advertised concentrations,” the study’s authors concluded.
The topical application of hemp-derived cannabinoids produced results that were superior to those associated with prescription treatments.
Ninety-one percent of military veterans surveyed said that “medicinal cannabis treatment helped them to experience a greater quality of life.”
Edible products dominant in CBD were associated with greater improvements in pain intensity and sleep quality than were products high in THC
The new regulations permit physicians to authorize medical cannabis access to patients diagnosed with irritable bowel syndrome (IBS) and/or obsessive-compulsive disorder.
“Our data show that chronic cannabis use may be associated with … suppression of the neuroinflammatory response following soccer heading,” investigators concluded.
NBA players will no longer be drug tested for cannabis.